Status:
RECRUITING
BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
Lead Sponsor:
Technical University of Madrid
Collaborating Sponsors:
University of Oslo
PREDICTBY RESEARCH AND CONSULTING S.L.
Conditions:
Cardiovascular Diseases
Endocrinology
Eligibility:
All Genders
Phase:
NA
Brief Summary
Lack of adherence to treatment is a widespread issue worldwide, which leads to higher healthcare utilisation rates and even premature death. While the level of adherence may differ based on the specif...
Detailed Description
The aim of the study is to validate the B-COMPASS in real-life settings. Overall, the purpose is to provide evidence 1) to validate the B-COMPASS (primary purpose), and 2) to demonstrate the effective...
Eligibility Criteria
Inclusion Criteria:
- Having the diagnosis of the pilot sites target groups described above as per clinical assessment or validated diagnosis criteria
- Having the age of the pilot sites target groups described above
- Having accepted to participate in the study and provided written informed consent
- Having the availability to participate on all study activities
Exclusion Criteria:
- Individuals that do not fulfil ALL the inclusion criteria will be excluded to participate.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
3100 Patients enrolled
Trial Details
Trial ID
NCT06856902
Start Date
March 1 2025
End Date
September 30 2026
Last Update
April 1 2026
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
UDUS - Heinrich-Heine-University Duesseldorf
Düsseldorf, Germany
2
FISM - Italian Multiple Sclerosis Foundation
Genova, Italy
3
WDO - World Duchenne Organization
Veenendaal, Netherlands
4
AHUS - Akershus University Hospital
Lørenskog, Akershus, Norway, 1478